Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(5 sites)
United States
City of Hope, Duarte, California Washington University School of Medicine, St Louis, Missouri Roswell Park Cancer Institute, Buffalo, New York Tennessee Oncology, Nashville, Tennessee Fred Hutchinson Cancer Center, Seattle, Washington